Cidara Completes its Initial Public Offering

San Diego – April 24, 2015 – Cooley advised Cidara Therapeutics, Inc. on its initial public offering. Cidara, headquartered in San Diego, California, is a biotechnology company focused on the discovery, development and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard-of-care therapies. The company trades on The NASDAQ Global Market under the symbol "CDTX."

About Cooley LLP

Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, often where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Susan Cooper Philpot Retired Partner, San Francisco
Charles Bair Partner, San Diego
Charlie Kim Partner, San Diego
Natasha Leskovsek Partner, Washington, DC
Karen Elizabeth Deschaine Partner, San Diego
Phil Mitchell Partner, New York
Phillip McGill Associate, San Diego
Nicole P. van de Leuv Associate, San Diego